NCT07729956
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Clinical trial condition
Triple-Negative Breast Cancer (TNBC)
Explore clinical trials studying Triple-Negative Breast Cancer (TNBC). Study availability and eligibility vary by location and protocol.
21 public trials
10 recruiting studies
Triple-Negative Breast Cancer (TNBC) trial results
Not Yet Recruiting
Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC
NCT07698106
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
Not specified
Not Yet Recruiting
Tislelizumab in Combination With Bevacizumab and Capecitabine in Advanced Solid Tumors With Evaluation in Immunotherapy-Resistant and Central Nervous System Disease
NCT07681297
- Conditions
- Advanced Solid Tumor Cancer, Breast Cancer, Breast Diseases, +10 more
- Locations
-
- National University Cancer Institute, Singapore, National University Health System Singapore
Not Yet Recruiting
Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC)
NCT07581314
- Conditions
- Advanced Triple-Negative Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
Not specified
Not Yet Recruiting
QLC5513 Alone or in Combination With QL1706 in Previously Treated Advanced or Metastatic TNBC.
NCT07509515
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
Not specified
NCT07005583
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, China
Not Yet Recruiting
Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)
NCT06975644
- Conditions
- Breast Diseases, Breast Neoplasms, Chemotherapy Effects, +7 more
- Locations
-
Not specified
Not Yet Recruiting
Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer
NCT06910072
- Conditions
- Breast Diseases, Breast Neoplasms, Neoadjuvant Therapy, +6 more
- Locations
-
- Cancer Hospital, Chinese Academy of Medical Sciences Beijing, China
NCT07714382
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- Sohag university Sohag, Egypt
Active, Not Recruiting
Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer
NCT07484776
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- Universidad Europea de Madrid, Villaviciosa de Odón Madrid, Spain